MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1513/annalsats.201405-188oc

Медицинская библиотека · Annals of the American Thoracic Society · 2014

Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.

Tagmouti Saloua, Slater Madeline, Benedetti Andrea, Kik Sandra V, Banaei Niaz, Cattamanchi Adithya, Metcalfe John, Dowdy David, van Zyl Smit Richard, Dendukuri Nandini, Pai Madhukar, Denkinger Claudia

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАСистематический обзорПеревод пока не подготовлен

Аннотация

RATIONALE: Interferon gamma (IFN-γ) release assays for latent tuberculosis infection result in a larger-than-expected number of conversions and reversions in occupational screening programs, and reproducibility of test results is a concern.

OBJECTIVES

Knowledge of the relative contribution and extent of the individual sources of variability (immunological, preanalytical, or analytical) could help optimize testing protocols.

METHODS

We performed a systematic review of studies published by October 2013 on all potential sources of variability of commercial IFN-γ release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB). The included studies assessed test variability under identical conditions and under different conditions (the latter both overall and stratified by individual sources of variability). Linear mixed effects models were used to estimate within-subject SD.

MEASUREMENTS AND MAIN

RESULTS

We identified a total of 26 articles, including 7 studies analyzing variability under the same conditions, 10 studies analyzing variability with repeat testing over time under different conditions, and 19 studies reporting individual sources of variability. Most data were on QuantiFERON (only three studies on T-SPOT.TB). A considerable number of conversions and reversions were seen around the manufacturer-recommended cut-point. The estimated range of variability of IFN-γ response in QuantiFERON under identical conditions was ±0.47 IU/ml (coefficient of variation, 13%) and ±0.26 IU/ml (30%) for individuals with an initial IFN-γ response in the borderline range (0.25-0.80 IU/ml). The estimated range of variability in noncontrolled settings was substantially larger (±1.4 IU/ml; 60%). Blood volume inoculated into QuantiFERON tubes and preanalytic delay were identified as key sources of variability.

CONCLUSIONS

This systematic review shows substantial variability with repeat IFN-γ release assays testing even under identical conditions, suggesting that reversions and conversions around the existing cut-point should be interpreted with caution.

Для цитирования: Tagmouti Saloua, Slater Madeline, Benedetti Andrea, Kik Sandra V, Banaei Niaz, Cattamanchi Adithya, Metcalfe John, Dowdy David, van Zyl Smit Richard, Dendukuri Nandini, Pai Madhukar, Denkinger Claudia. Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.. Annals of the American Thoracic Society. 2014. DOI: 10.1513/annalsats.201405-188oc.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.